Symbols

Nektar Therapeutics Soars 12.94% on Jefferies Upgrade

Generated by AI AgentAinvest Movers Radar

Monday, Apr 14, 2025 7:06 am ET1min read

Nektar Therapeutics' stock surged by 12.94% in pre-market trading on April 14, 2025, marking a significant rise in investor confidence.

Nektar Therapeutics (NKTR) recently experienced a notable stock surge following an upgrade to a "Buy" rating by Jefferies. The investment firm highlighted the company's potential for growth and innovation, which likely contributed to the positive market sentiment.

Verition Fund Management LLC has increased its stake in Nektar TherapeuticsNKTR--, acquiring an additional 100,454 shares in the last quarter. This move by a prominent investment firm suggests a strong belief in the company's future prospects and may have influenced the recent stock price increase.

Ainvest Movers Radar

Knowing stock market today at a glance

Latest Articles

Stay ahead of the market.

Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments

﻿

Add a public comment...

No comments yet

AInvest
PRO

Editorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process. While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context. Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue